VCYT Veracyte
Veracyte earnings company data as of 10:27 PM ET 11/12
- 1 of 1 EPS beats
History
1 period, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | 0.28 | 0.51 | Beat +82.1% |
| Rev | $147.1M | $151.8M | Beat +3.2% |
Insider trades
Open-market buys and sales by VCYT's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $1.1M sold by 1 insider outside a trading plan
- $17.7M sold by 10 insiders under 10b5-1 plans
-
Jens Holstein DirectorPlanned sale$728K 15,000 shares at $48.50 35% of stakeTraded Sep 24–Oct 27 Filed Oct 28
-
Karin Eastham DirectorPlanned sale$743K 14,850 shares at $50.00 59% of stakeTraded Oct 27 Filed Oct 28
-
Muna Bhanji DirectorPlanned sale$81K 1,864 shares at $43.70 4.4% of stakeTraded Oct 19 Filed Oct 20
-
John Leite Global Chief Commercial OffPlanned sale$161K 4,015 shares at $40.00 3.1% of stakeTraded Sep 21 Filed Sep 22
-
Jens Holstein DirectorPlanned sale$205K 5,000 shares at $40.95 15% of stakeTraded Sep 14 Filed Sep 16
-
Annie McGuire EVP, General CounselPlanned sale$140K 3,254 shares at $43.09 2.4% of stakeTraded Sep 4 Filed Sep 4
-
Rebecca Chambers CFOPlanned sale$157K 3,652 shares at $43.10 2.2% of stakeTraded Sep 4 Filed Sep 4
-
Phillip G. Febbo Chief Scientific & Med OfficerPlanned sale$564K 13,110 shares at $43.05 9% of stakeTraded Sep 4 Filed Sep 4
-
Muna Bhanji DirectorPlanned sale$80K 1,864 shares at $42.97 4.2% of stakeTraded Sep 1 Filed Sep 3
-
Karin Eastham DirectorPlanned sale$197K 3,729 shares at $52.89 20% of stakeTraded Jun 18 Filed Jun 22
-
John Leite Global Chief Commercial OffPlanned sale$700K 13,975 shares at $50.07 9.6% of stakeTraded Jun 4 Filed Jun 4
-
Annie McGuire EVP, General CounselPlanned sale$158K 3,176 shares at $49.76 2.3% of stakeTraded Jun 4 Filed Jun 4
-
Rebecca Chambers CFOPlanned sale$177K 3,561 shares at $49.73 2% of stakeTraded Jun 4 Filed Jun 4
-
Marc Stapley CEOPlanned sale$6.9M 138,051 shares at $50.12 24% of stakeTraded Jun 4 Filed Jun 4
-
Jonathan Wygant VP, Chief Accounting OfficerSale$1.1M 24,000 shares at $45.40 35% of stakeTraded May 22 Filed May 27
Also filed in the last 12 months, not counted as buying or selling: 30 share withholdings for taxes, 24 stock grants, and 7 option exercises.
SEC filings
Recent issuer filings from EDGAR, 10 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,8.01,9.01 | Filing Doc | |
| 8-K | 1.01,2.01,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 5.02,5.07 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon
- Financial Intelligence, Revised Ed. View on Amazon